CSL Behring - Company & Market Research Reports

Home /
Companies /
CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

REFINE BY

KEYWORD

Anticoagulant Reversal Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
120 Pages
Global

From

€4444EUR$4,500USD£3,698GBP

Middle East And Africa Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

 Report
May 2023
79 Pages
Middle East, Africa

From

€2148EUR$2,175USD£1,787GBP

Complement C1 inhibitors - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1037EUR$1,050USD£863GBP

€1481EUR$1,500USD£1,233GBP

Alpha 1 Antitrypsin Deficiency Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
75 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034

 Report
August 2024
287 Pages
Global

From

€5496EUR$5,565USD£4,573GBP

€7852EUR$7,950USD£6,533GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Recombinant Plasma Protein Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

 Report
October 2021
102 Pages
Global

From

€4444EUR$4,500USD£3,698GBP

C1 Esterase Inhibitor - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€864EUR$875USD£719GBP

€1235EUR$1,250USD£1,027GBP

Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Regional Outlook and Forecast, 2023-2029

 Report
April 2023
231 Pages
Global

From

€3556EUR$3,600USD£2,958GBP

Plasma Protein Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
October 2024
96 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Complement C1s inhibitors - Pipeline Insight, 2024

 Drug Pipelines
January 2024
60 Pages
Global

From

€1037EUR$1,050USD£863GBP

€1481EUR$1,500USD£1,233GBP

Interleukin 6 inhibitors - Pipeline Insight, 2024

 Drug Pipelines
January 2024
60 Pages
Global

From

€1037EUR$1,050USD£863GBP

€1481EUR$1,500USD£1,233GBP

AR/VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

 Report
June 2020
190 Pages
Global

From

€4838EUR$4,899USD£4,026GBP

Blood Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
120 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Surgical Sealants Glues Hemostat Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

C1 Esterase Inhibitor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
72 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Tissue Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
100 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3950EUR$3,999USD£3,286GBP

Cell and Gene Therapies in Rare Disorders - Market Insights, Epidemiology and Market Forecast - 2032

 Report
April 2023
399 Pages
Global

From

€6568EUR$6,650USD£5,465GBP

€9383EUR$9,500USD£7,807GBP

Japan Rare Disease Diagnostics Market, Competition, Forecast & Opportunities, 2018-2028

 Report
October 2023
90 Pages
Japan

From

€3457EUR$3,500USD£2,876GBP

Chronic Inflammatory Demyelinating Polyneuropathy Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5925EUR$5,999USD£4,930GBP

290 Results (Page 13 of 15)
- 1
- 11
- 12
- 13
- 14
- 15

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.